Evidence map›Paper›PMID 31293658›Full record

ArticleJournal of Cancer2019

HCCR-1 is a Novel Prognostic Indicator for Gastric Cancer and Promotes Cell Proliferation.

Liang-Fei Zhu, Peng Ma, Yi-Lin Hu, Ying Feng, Peng Li, Hua Wang, Yi-Bing Guo, Qin-Sheng Mao, Wan-Jiang Xue

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Liang-Fei ZhuDepartment of Gastrointestinal Surgery , Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China.
Peng MaDepartment of Gastrointestinal Surgery , Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China.
Yi-Lin HuDepartment of Gastrointestinal Surgery , Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China.
Ying FengDepartment of Gastrointestinal Surgery , Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China.
Peng LiDepartment of Gastrointestinal Surgery , Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China.
Hua WangDepartment of Pathology, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China.
Yi-Bing GuoResearch Center of Clinical Medicine, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China.
Qin-Sheng MaoDepartment of Gastrointestinal Surgery , Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China.
Wan-Jiang XueDepartment of Gastrointestinal Surgery , Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China.
Nantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of the human cervical cancer oncogene (

Indexed as

CarcinogenesisClinicopathological characteristicsGastric cancerHCCR-1OncogenePrognosis

Identifiers

PMID31293658
PMCPMC6603419
OpenAlexW2952454468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.